Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Bone marrow transplantation may be able to replace immune cells that were
destroyed by chemotherapy or radiation therapy used to kill cancer cells. Sometimes the
transplanted cells from a donor can make an immune response against the body's normal cells.
Eliminating the T cells from the donor cells before transplanting them may prevent this from
happening.
PURPOSE: Randomized phase II/III trial to compare the effectiveness of conventional bone
marrow transplantation with T cell-depleted bone marrow transplantation in treating patients
who have leukemia, myelodysplasia, or lymphoblastic lymphoma.